IMAT 100MG

Manufacturer
BIOCHEM PHARMACUTICLAS INDUSTRIES
Packaging
Strip
Composition
IMATINIB MESYLATE (100MG)
Availability
OTC
SKU
PROD-00871

Product Description

🔹 Product Overview
IMAT 100 mg Tablet contains Imatinib Mesylate 100 mg, an oral prescription anticancer medicine belonging to the tyrosine kinase inhibitor (TKI) class. It is used to treat specific cancers and blood disorders, including certain forms of chronic myeloid leukemia (CML), acute lymphoblastic leukemia (ALL), gastrointestinal stromal tumors (GIST), and other conditions for which imatinib is indicated.

🔹 Key Uses
Treatment of certain types of chronic myeloid leukemia (CML)
Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) in appropriate patients
Treatment of gastrointestinal stromal tumors (GIST)
Treatment of dermatofibrosarcoma protuberans (DFSP) in appropriate cases
May be used for certain rare blood disorders such as systemic mastocytosis when specifically indicated
Helps control the growth and multiplication of abnormal cancer cells

🔹 Composition
Active ingredient: Imatinib Mesylate 100 mg
Drug class: Tyrosine kinase inhibitor
Therapeutic category: Anticancer / antineoplastic medicine
Dosage form: Tablet
Route: Oral
Prescription status: Prescription medicine

🔹 How It Works
Imatinib selectively blocks certain abnormal tyrosine kinase proteins involved in cancer-cell signaling. In diseases such as CML, it inhibits the BCR-ABL tyrosine kinase, which is responsible for continuous abnormal cell growth. By blocking these signals, imatinib helps slow the proliferation of susceptible cancer cells and can promote their programmed cell death.

🔹 Key Benefits
Helps control the growth of certain cancer cells
Provides targeted treatment for specific blood cancers
Helps manage CML by inhibiting BCR-ABL signaling
Provides an oral treatment option for appropriate patients with GIST
May help control other imatinib-sensitive tumors and blood disorders
Can support long-term disease control when used according to an oncologist's treatment plan

🔹 Dosage and Administration
The appropriate dose of IMAT 100 mg depends on the specific disease, treatment stage, response to therapy, and the patient's overall health. Imatinib doses can vary considerably between conditions, so 100 mg should not be assumed to be the standard daily dose.
Take IMAT exactly as prescribed by your oncologist. It is generally taken with food and a large glass of water to reduce gastrointestinal irritation. Swallow the tablet whole unless your healthcare professional provides alternative administration instructions.
Do not stop treatment or change the dose without consulting your doctor.

🔹 Possible Side Effects
Possible side effects include:
Nausea
Vomiting
Diarrhea
Abdominal discomfort
Headache
Muscle or joint pain
Muscle cramps
Skin rash
Fatigue
Swelling or fluid retention
Weight gain
Changes in blood-cell counts
Increased liver enzymes

🔹 Precautions
IMAT should be used under specialist medical supervision.
Tell your doctor if you have:
Liver disease
Kidney problems
Heart disease or heart failure
Thyroid disorders
A history of significant bleeding
Low blood-cell counts
Any known allergy to imatinib
Any other medical condition

Additional Information

  • Category: category change
  • Manufacturer: BIOCHEM PHARMACUTICLAS INDUSTRIES
  • Packaging: Strip
  • Composition: IMATINIB MESYLATE (100MG)
  • Storage: Store in a cool, dry place away from direct sunlight
  • Shelf Life: As per manufacturer's guidelines
  • Prescription Status: Over-the-Counter (OTC)

How to Use

Important: Always follow your healthcare provider's instructions when using this medication.

  • Take this medicine as directed by your physician
  • Do not exceed the recommended dosage
  • Complete the full course of treatment even if symptoms improve
  • Store the medication properly as per storage instructions
  • Keep out of reach of children
  • Check expiry date before use

Note: This is general guidance. For specific instructions, please consult your healthcare provider or refer to the package insert.